EED - Eye Exam for Patient with Diabetes
Product Lines:
Advantage MD, EHP, Priority Partners, and USFHP.
Eligible Population:
Members 18-75 years old as of December 31 of the measurement year
Definition:
Percentage of diabetic (types 1 and 2) members who had the following:
- Eye Exam:
- A retinal or dilated eye exam to detect retinopathy performed by an ophthalmologist or optometrist.
- A diagnosis of retinopathy or an eye exam with an unknown retinal status requires an annual exam.
- If negative for retinopathy, a bi-annual exam meets criteria.
- Members with bilateral eye enucleation are considered compliant.
Provider Specialty: Ophthalmologist or Optometrist.
New for Measure: Stratification by race and ethnicity.
Continuous Enrollment:
- The measurement year.
Best Practice and Measure Tips
- Provide member education on risks of Diabetic Eye Disease, and encourage scheduling annual exam.
- Obtain eye exam reports. Notate eye care provider name and demographics in chart if report not available.
- The dilated or retinal exam: it is best practice to have a bilateral retinal exam unless there is history of a unilateral eye enucleation.
- In some instances a unilateral retinal / dilated exam may be used if it meets guidelines for acceptable documentation.
- Documentation can be in the form of a note or letter prepared by an ophthalmologist, optometrist, PCP or other health care professional. Include: date of service, the test (indicate a dilated or retinal exam) or result, and the care provider’s credentials.
- Documentation example: “Last diabetic retinal eye exam with John Smith, OD, was June 201X with no retinopathy.”
- Must indicate performed by Optometrist or Ophthalmologist.
- A slit-lamp examination must have documentation of dilation or evidence that the retina was examined to be considered compliant.
- Examination of macula, vessels and periphery without eye dilation meets criteria for a "retinal exam."
- A chart or photograph with date of fundus photography or retinal imaging (Example: Computerized Ophthalmic Imaging such as Optical Coherence Tomography - OCT) and one of the following is acceptable:
- Results read by a qualified reading center or by a system that provides an artificial intelligence (AI) interpretation.
- Results reviewed by an eye care professional.
- Results read by a qualified reading center operating under the direction of a medical director who is a retinal specialist.
- Prior year exam results must indicate retinopathy was not present.
- AI Reports:
- Acceptable: “Negative for more than mild diabetic retinopathy”: This is only considered a negative result when it is a result of an exam read by AI (IDx-DR imaging system).
- Documentation of Provider type for AI Reports:
- If it is noted that an Optometrist or Ophthalmologist reviewed the AI results, then choose the appropriate provider type in the dropdown.
- Some of the reports state they were read by AI and do not list a provider. If so, choose the provider dropdown option, “Results read by a system that provides an artificial intelligence (AI) interpretation.
Not Acceptable:
- Routine fundoscopic exam without examination of macula, vessels and periphery.
- Documentation of "diabetes without complications."
- Exams performed by PCP or non-eye care professionals (optician)
- Refractive only exams
- Exams in which only the anterior (A) chamber of the eye is examined
- Glaucoma pressure checks
- Unilateral post-op eye exams which do not meet guidelines for acceptable documentation
Measure Exclusions
Required Exclusions:
- Palliative Care
- Members in hospice or using hospice services anytime during the measurement year.
- Members who died any time during the measurement year.
- Frailty and Advanced Illness
- Living in Long Term Care
NOTE: Blindness is not an exclusion for a diabetic eye exam because it is difficult to distinguish between individuals who are legally blind but require a retinal exam and those who are completely blind and therefore do not require an exam.
Measure Codes
- Diabetes Mellitus Without Complications
- ICD-10-CM: E10.9, E11.9, E13.9
- Diabetic Eye Exam by any provider type:
- Current year or prior year dilated retinal screening with evidence of retinopathy:
- CPT II: 2022F, 2024F, 2026F
- Current year dilated retinal screening without evidence of retinopathy:
- CPT II: 2023F, 2025F, 2033F
- Prior year dilated negative retinal screening:
- CPT II: 3072F
- Automated Eye Exam:
- CPT: 92229
- Current year or prior year dilated retinal screening with evidence of retinopathy:
- Diabetic Retinal Screening with Eye Care Professional
- CPT: 67028, 67030, 67031, 67036, 67039-67043, 67101, 67105, 67107, 67108, 67110, 67113, 67121, 67141, 67145, 67208, 67210, 67218, 67220, 67221, 67227, 67228, 92002, 92004, 92012, 92014, 92018, 92019, 92134, 92201, 92202, 92227, 92228, 92230, 92235, 92240, 92250, 92260, 99203-99205, 99213-99215, 99242-99245
- HCPCS: S0620, S0621, S3000
- Unilateral Eye Enucleation
- CPT: 65091, 65093, 65101, 65103, 65105, 65110, 65112, 65114
- Unilateral Eye Enucleation – Left
- ICD10PCS: Diagnosis 08T1XZZ
- Unilateral Eye Enucleation – Right
- ICD10PCS: Diagnosis 08T0XZZ
- Bilateral Modifier
- CPT Modifier 50
Medication List: Diabetes Medications
Description | Prescription |
---|---|
Alpha-glucosidase inhibitors |
|
Amylin analogs |
|
Antidiabetic combinations |
|
Insulin |
|
Meglitinides |
|
Biguanides |
|
Glucagon-like peptide-1 (GLP1) agonists |
|
Sodium glucose cotransporter 2 (SGLT2) inhibitor |
|
Sulfonylureas |
|
Thiazolidinediones |
|
Dipeptidyl peptidase-4 (DDP-4) inhibitors |
|